These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29975799)

  • 81. Epilepsy specialist nurse prescribing practice in the United Kingdom: a national questionnaire survey.
    Goodwin M; Higgins S; Lewis S
    Seizure; 2011 Dec; 20(10):754-7. PubMed ID: 21868259
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Knowledge of the pharmacological profile of a patient improves the quality of prescribing, the outcomes of treatment, and the utilization of health services in primary health care.
    Stefanovic SM; Jankovic SM
    Eur J Clin Pharmacol; 2011 Nov; 67(11):1091-101. PubMed ID: 21573692
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evaluation of the prescribing decision support system Synonyms in a primary care setting: a mixed-method study.
    Robertson LA; McLean MA; Montgomery Sardar C; Bryson G; Kurdi A
    Int J Pharm Pract; 2020 Oct; 28(5):473-482. PubMed ID: 32390231
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Does variation among provincial drug formulary antimicrobial listings in Canada influence prescribing rates?
    Glass-Kaastra SK; Finley R; Hutchinson J; Patrick DM; Weiss K; Conly J
    PLoS One; 2014; 9(9):e107515. PubMed ID: 25203557
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Impact of a formulary on personal care homes in Manitoba.
    Yakabowich MR; Keeley G; Montgomery PR
    CMAJ; 1994 May; 150(10):1601-7. PubMed ID: 8174030
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019-2023.
    Knight KJ; Fordham RJ; Crabtree NJ; Knapp KM
    Osteoporos Int; 2024 Aug; 35(8):1451-1460. PubMed ID: 38795142
    [TBL] [Abstract][Full Text] [Related]  

  • 87. How many medications do doctors in primary care use? An observational study of the DU90% indicator in primary care in England.
    Chiedozie C; Murphy ME; Fahey T; Moriarty F
    BMJ Open; 2021 Mar; 11(3):e043049. PubMed ID: 33653750
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The scale of repeat prescribing--time for an update.
    Petty DR; Zermansky AG; Alldred DP
    BMC Health Serv Res; 2014 Feb; 14():76. PubMed ID: 24552190
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Adherence to prescribing recommendations made on a provincial formulary.
    Hildebrand AM; Yao Z; Gomes T; Camacho X; Garg AX; Juurlink DN
    Healthc Policy; 2014 May; 9(4):20-30. PubMed ID: 24973481
    [TBL] [Abstract][Full Text] [Related]  

  • 90. How do doctors and patients react to the introduction of a practice formulary?
    Field J
    Fam Pract; 1989 Jun; 6(2):135-40. PubMed ID: 2744298
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Medicines prescribed by non-medical independent prescribers in primary care in Wales: a 10-year longitudinal study April 2011-March 2021.
    Deslandes P; Blowers H; Haines K; Hodson K; Deslandes R
    BMJ Open; 2022 Feb; 12(2):e059204. PubMed ID: 35210350
    [TBL] [Abstract][Full Text] [Related]  

  • 92. 10-year trends in English primary care glaucoma prescribing.
    Hogg HDJ; Connor A
    Eye (Lond); 2020 Jan; 34(1):192-196. PubMed ID: 31685974
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Improving Injectable Medicines Prescription in Outpatient Services: A Path Towards Rational Use of Medicines in Iran.
    Bairami F; Soleymani F; Rashidian A
    Int J Health Policy Manag; 2016 Mar; 5(5):321-4. PubMed ID: 27239881
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacy compounding primer for physicians: prescriber beware.
    Sellers S; Utian WH
    Drugs; 2012 Nov; 72(16):2043-50. PubMed ID: 23039281
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The general practice formulary--its role in rational therapeutics.
    Green PE
    J R Coll Gen Pract; 1985 Dec; 35(281):570-2. PubMed ID: 4093901
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Development of a limited formulary for general practice.
    Grant GB; Gregory DA; van Zwanenberg TD
    Lancet; 1985 May; 1(8436):1030-2. PubMed ID: 2859474
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Medicines prescription patterns in European neonatal units.
    Mesek I; Nellis G; Lass J; Metsvaht T; Varendi H; Visk H; Turner MA; Nunn AJ; Duncan J; Lutsar I
    Int J Clin Pharm; 2019 Dec; 41(6):1578-1591. PubMed ID: 31625122
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The development of a national children's formulary.
    Lenney W
    Br J Clin Pharmacol; 2015 Mar; 79(3):441-5. PubMed ID: 24215142
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prescribing costs when computers are used to issue all prescriptions.
    Donald JB
    BMJ; 1989 Jul; 299(6690):28-30. PubMed ID: 2503199
    [TBL] [Abstract][Full Text] [Related]  

  • 100. What do prescribers think of biosimilars?
    Aapro MS
    Target Oncol; 2012 Mar; 7 Suppl 1():S51-5. PubMed ID: 22258706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.